PubMed:25885172
Annnotations
maxiaofeng52_800
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 319-343 | DP | denotes | type 2 diabetes mellitus |
| T2 | 345-349 | DP | denotes | T2DM |
| T3 | 134-149 | DP | denotes | type 2 diabetes |
| T4 | 30-41 | CI | denotes | PF-04937319 |
| T5 | 109-118 | CI | denotes | metformin |
| T6 | 400-411 | CI | denotes | PF-04937319 |
| T7 | 257-268 | CI | denotes | PF-04937319 |
| T8 | 478-489 | CI | denotes | PF-04937319 |
| T9 | 909-920 | CI | denotes | PF-04937319 |
| T10 | 977-988 | CI | denotes | PF-04937319 |
| T11 | 1489-1500 | CI | denotes | PF-04937319 |
| T12 | 1625-1636 | CI | denotes | PF-04937319 |
| T13 | 1813-1824 | CI | denotes | PF-04937319 |
| T14 | 291-300 | CI | denotes | metformin |
| T15 | 1757-1766 | CI | denotes | metformin |
| T16 | 565-576 | CI | denotes | glimepiride |
| T17 | 597-608 | CI | denotes | sitagliptin |
| T18 | 1251-1262 | CI | denotes | glimepiride |
| T19 | 1715-1726 | CI | denotes | glimepiride |
| T20 | 1170-1181 | CI | denotes | sitagliptin |
| T21 | 1667-1678 | CI | denotes | sitagliptin |
Zierdiyeerkenaili_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 30-41 | CI | denotes | PF-04937319 |
| T2 | 257-268 | CI | denotes | PF-04937319 |
| T3 | 400-411 | CI | denotes | PF-04937319 |
| T4 | 478-489 | CI | denotes | PF-04937319 |
| T5 | 909-920 | CI | denotes | PF-04937319 |
| T6 | 977-988 | CI | denotes | PF-04937319 |
| T7 | 1489-1500 | CI | denotes | PF-04937319 |
| T8 | 1625-1636 | CI | denotes | PF-04937319 |
| T9 | 1813-1824 | CI | denotes | PF-04937319 |
| T10 | 530-537 | CI | denotes | placebo |
| T11 | 449-456 | CI | denotes | placebo |
| T12 | 1111-1118 | CI | denotes | placebo |
| T13 | 1433-1440 | CI | denotes | placebo |
| T14 | 1594-1601 | CI | denotes | placebo |
| T15 | 565-576 | CI | denotes | glimepiride |
| T16 | 1251-1262 | CI | denotes | glimepiride |
| T17 | 1715-1726 | CI | denotes | glimepiride |
| T18 | 597-608 | CI | denotes | sitagliptin |
| T19 | 1170-1181 | CI | denotes | sitagliptin |
| T20 | 1667-1678 | CI | denotes | sitagliptin |
| T21 | 134-149 | DP | denotes | type 2 diabetes |
| T23 | 109-118 | CI | denotes | metformin |
| T24 | 291-300 | CI | denotes | metformin |
| T25 | 1757-1766 | CI | denotes | metformin |
| T26 | 345-349 | DP | denotes | T2DM |
| T27 | 319-343 | DP | denotes | type 2 diabetes mellitus |
yaoziqian_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 30-41 | CI | denotes | PF-04937319 |
| T10 | 478-489 | CI | denotes | PF-04937319 |
| T12 | 909-920 | CI | denotes | PF-04937319 |
| T13 | 977-988 | CI | denotes | PF-04937319 |
| T14 | 1489-1500 | CI | denotes | PF-04937319 |
| T15 | 1813-1824 | CI | denotes | PF-04937319 |
| T16 | 1625-1636 | CI | denotes | PF-04937319 |
| T17 | 565-576 | CI | denotes | glimepiride |
| T18 | 1251-1262 | CI | denotes | glimepiride |
| T19 | 1715-1726 | CI | denotes | glimepiride |
| T2 | 134-149 | DP | denotes | type 2 diabetes |
| T20 | 1667-1678 | CI | denotes | sitagliptin |
| T21 | 597-608 | CI | denotes | sitagliptin |
| T22 | 1170-1181 | CI | denotes | sitagliptin |
| T23 | 109-118 | CI | denotes | metformin |
| T24 | 1757-1766 | CI | denotes | metformin |
| T4 | 257-268 | CI | denotes | PF-04937319 |
| T5 | 291-300 | CI | denotes | metformin |
| T6 | 319-343 | DP | denotes | type 2 diabetes mellitus |
| T7 | 345-349 | DP | denotes | T2DM |
| T8 | 400-411 | CI | denotes | PF-04937319 |
| T25 | 449-456 | CI | denotes | placebo |
| T26 | 530-537 | CI | denotes | placebo |
| T27 | 1111-1118 | CI | denotes | placebo |
| T28 | 1433-1440 | CI | denotes | placebo |
| T29 | 1594-1601 | CI | denotes | placebo |